| Product Code: ETC6740125 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Communicable Diseases Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Communicable Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China Communicable Diseases Treatment Market - Industry Life Cycle |
3.4 China Communicable Diseases Treatment Market - Porter's Five Forces |
3.5 China Communicable Diseases Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Communicable Diseases Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 China Communicable Diseases Treatment Market Revenues & Volume Share, By Infectious Agent, 2021 & 2031F |
3.8 China Communicable Diseases Treatment Market Revenues & Volume Share, By Mode of Transmission, 2021 & 2031F |
3.9 China Communicable Diseases Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 China Communicable Diseases Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 China Communicable Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of communicable diseases in China |
4.2.2 Rising awareness about the importance of early diagnosis and treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to treatment |
4.3 Market Restraints |
4.3.1 High cost of advanced treatment options |
4.3.2 Limited healthcare resources in rural areas |
4.3.3 Lack of skilled healthcare professionals specializing in communicable diseases |
5 China Communicable Diseases Treatment Market Trends |
6 China Communicable Diseases Treatment Market, By Types |
6.1 China Communicable Diseases Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Communicable Diseases Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 China Communicable Diseases Treatment Market Revenues & Volume, By Gastroenteritis, 2021- 2031F |
6.1.4 China Communicable Diseases Treatment Market Revenues & Volume, By Gonorrhoea, 2021- 2031F |
6.1.5 China Communicable Diseases Treatment Market Revenues & Volume, By Whooping Cough, 2021- 2031F |
6.1.6 China Communicable Diseases Treatment Market Revenues & Volume, By Common Cold, 2021- 2031F |
6.1.7 China Communicable Diseases Treatment Market Revenues & Volume, By HIV/AIDS, 2021- 2031F |
6.1.8 China Communicable Diseases Treatment Market Revenues & Volume, By Pink Eye, 2021- 2031F |
6.1.9 China Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 China Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Communicable Diseases Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 China Communicable Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.3 China Communicable Diseases Treatment Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2.4 China Communicable Diseases Treatment Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.2.5 China Communicable Diseases Treatment Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.2.6 China Communicable Diseases Treatment Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.2.7 China Communicable Diseases Treatment Market Revenues & Volume, By Antiparasitics, 2021- 2031F |
6.2.8 China Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 China Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Communicable Diseases Treatment Market, By Infectious Agent |
6.3.1 Overview and Analysis |
6.3.2 China Communicable Diseases Treatment Market Revenues & Volume, By Bacteria, 2021- 2031F |
6.3.3 China Communicable Diseases Treatment Market Revenues & Volume, By Viruses, 2021- 2031F |
6.3.4 China Communicable Diseases Treatment Market Revenues & Volume, By Fungi/Parasites, 2021- 2031F |
6.4 China Communicable Diseases Treatment Market, By Mode of Transmission |
6.4.1 Overview and Analysis |
6.4.2 China Communicable Diseases Treatment Market Revenues & Volume, By Direct Contact, 2021- 2031F |
6.4.3 China Communicable Diseases Treatment Market Revenues & Volume, By Person-to-person Contact, 2021- 2031F |
6.4.4 China Communicable Diseases Treatment Market Revenues & Volume, By Droplet Spread, 2021- 2031F |
6.4.5 China Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4.6 China Communicable Diseases Treatment Market Revenues & Volume, By Indirect Contact, 2021- 2031F |
6.4.7 China Communicable Diseases Treatment Market Revenues & Volume, By Airborne Transmission, 2021- 2031F |
6.4.8 China Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.4.9 China Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.5 China Communicable Diseases Treatment Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 China Communicable Diseases Treatment Market Revenues & Volume, By Sexually Transmitted Diseases, 2021- 2031F |
6.5.3 China Communicable Diseases Treatment Market Revenues & Volume, By Helminthic Diseases, 2021- 2031F |
6.5.4 China Communicable Diseases Treatment Market Revenues & Volume, By Contact Communicable Diseases, 2021- 2031F |
6.5.5 China Communicable Diseases Treatment Market Revenues & Volume, By Oral Contamination Diseases, 2021- 2031F |
6.5.6 China Communicable Diseases Treatment Market Revenues & Volume, By Air Borne Diseases, 2021- 2031F |
6.6 China Communicable Diseases Treatment Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 China Communicable Diseases Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China Communicable Diseases Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 China Communicable Diseases Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 China Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 China Communicable Diseases Treatment Market Import-Export Trade Statistics |
7.1 China Communicable Diseases Treatment Market Export to Major Countries |
7.2 China Communicable Diseases Treatment Market Imports from Major Countries |
8 China Communicable Diseases Treatment Market Key Performance Indicators |
8.1 Percentage increase in the number of patients seeking treatment for communicable diseases |
8.2 Utilization rate of diagnostic services for communicable diseases |
8.3 Percentage of the population covered by government-funded treatment programs |
9 China Communicable Diseases Treatment Market - Opportunity Assessment |
9.1 China Communicable Diseases Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Communicable Diseases Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 China Communicable Diseases Treatment Market Opportunity Assessment, By Infectious Agent, 2021 & 2031F |
9.4 China Communicable Diseases Treatment Market Opportunity Assessment, By Mode of Transmission, 2021 & 2031F |
9.5 China Communicable Diseases Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 China Communicable Diseases Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 China Communicable Diseases Treatment Market - Competitive Landscape |
10.1 China Communicable Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 China Communicable Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here